510 related articles for article (PubMed ID: 25594542)
1. Lysosomal-associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease.
Murphy KE; Gysbers AM; Abbott SK; Spiro AS; Furuta A; Cooper A; Garner B; Kabuta T; Halliday GM
Mov Disord; 2015 Oct; 30(12):1639-47. PubMed ID: 25594542
[TBL] [Abstract][Full Text] [Related]
2. Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease.
Alvarez-Erviti L; Seow Y; Schapira AH; Rodriguez-Oroz MC; Obeso JA; Cooper JM
Cell Death Dis; 2013 Mar; 4(3):e545. PubMed ID: 23492776
[TBL] [Abstract][Full Text] [Related]
3. The lysosomal membrane protein LAMP2A promotes autophagic flux and prevents SNCA-induced Parkinson disease-like symptoms in the Drosophila brain.
Issa AR; Sun J; Petitgas C; Mesquita A; Dulac A; Robin M; Mollereau B; Jenny A; Chérif-Zahar B; Birman S
Autophagy; 2018; 14(11):1898-1910. PubMed ID: 29989488
[TBL] [Abstract][Full Text] [Related]
4. Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA).
Ho PW; Leung CT; Liu H; Pang SY; Lam CS; Xian J; Li L; Kung MH; Ramsden DB; Ho SL
Autophagy; 2020 Feb; 16(2):347-370. PubMed ID: 30983487
[TBL] [Abstract][Full Text] [Related]
5. LAMP2A, LAMP2B and LAMP2C: similar structures, divergent roles.
Qiao L; Hu J; Qiu X; Wang C; Peng J; Zhang C; Zhang M; Lu H; Chen W
Autophagy; 2023 Nov; 19(11):2837-2852. PubMed ID: 37469132
[TBL] [Abstract][Full Text] [Related]
6. Reduced expression of the chaperone-mediated autophagy carrier hsc70 protein in lymphomonocytes of patients with Parkinson's disease.
Sala G; Stefanoni G; Arosio A; Riva C; Melchionda L; Saracchi E; Fermi S; Brighina L; Ferrarese C
Brain Res; 2014 Feb; 1546():46-52. PubMed ID: 24361989
[TBL] [Abstract][Full Text] [Related]
7. Chaperone-mediated autophagy components are upregulated in sporadic inclusion-body myositis muscle fibres.
Cacciottolo M; Nogalska A; D'Agostino C; Engel WK; Askanas V
Neuropathol Appl Neurobiol; 2013 Dec; 39(7):750-61. PubMed ID: 23452232
[TBL] [Abstract][Full Text] [Related]
8. Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease.
Murphy KE; Gysbers AM; Abbott SK; Tayebi N; Kim WS; Sidransky E; Cooper A; Garner B; Halliday GM
Brain; 2014 Mar; 137(Pt 3):834-48. PubMed ID: 24477431
[TBL] [Abstract][Full Text] [Related]
9. VPS35 in Dopamine Neurons Is Required for Endosome-to-Golgi Retrieval of Lamp2a, a Receptor of Chaperone-Mediated Autophagy That Is Critical for α-Synuclein Degradation and Prevention of Pathogenesis of Parkinson's Disease.
Tang FL; Erion JR; Tian Y; Liu W; Yin DM; Ye J; Tang B; Mei L; Xiong WC
J Neurosci; 2015 Jul; 35(29):10613-28. PubMed ID: 26203154
[TBL] [Abstract][Full Text] [Related]
10. Lysosomal alterations in peripheral blood mononuclear cells of Parkinson's disease patients.
Papagiannakis N; Xilouri M; Koros C; Stamelou M; Antonelou R; Maniati M; Papadimitriou D; Moraitou M; Michelakakis H; Stefanis L
Mov Disord; 2015 Nov; 30(13):1830-4. PubMed ID: 26769460
[TBL] [Abstract][Full Text] [Related]
11. Targeted suppression of chaperone-mediated autophagy by miR-320a promotes α-synuclein aggregation.
Li G; Yang H; Zhu D; Huang H; Liu G; Lun P
Int J Mol Sci; 2014 Sep; 15(9):15845-57. PubMed ID: 25207598
[TBL] [Abstract][Full Text] [Related]
12. alpha-synuclein degradation by autophagic pathways: a potential key to Parkinson's disease pathogenesis.
Xilouri M; Vogiatzi T; Vekrellis K; Stefanis L
Autophagy; 2008 Oct; 4(7):917-9. PubMed ID: 18708765
[TBL] [Abstract][Full Text] [Related]
13. Regional deficiencies in chaperone-mediated autophagy underlie α-synuclein aggregation and neurodegeneration.
Malkus KA; Ischiropoulos H
Neurobiol Dis; 2012 Jun; 46(3):732-44. PubMed ID: 22426402
[TBL] [Abstract][Full Text] [Related]
14. A new perspective in Parkinson's disease, chaperone-mediated autophagy.
Li B; Zhang Y; Yuan Y; Chen N
Parkinsonism Relat Disord; 2011 May; 17(4):231-5. PubMed ID: 21215675
[TBL] [Abstract][Full Text] [Related]
15. Sigma-2 receptor antagonists rescue neuronal dysfunction induced by Parkinson's patient brain-derived α-synuclein.
Limegrover CS; Yurko R; Izzo NJ; LaBarbera KM; Rehak C; Look G; Rishton G; Safferstein H; Catalano SM
J Neurosci Res; 2021 Apr; 99(4):1161-1176. PubMed ID: 33480104
[TBL] [Abstract][Full Text] [Related]
16. Rotenone upregulates alpha-synuclein and myocyte enhancer factor 2D independently from lysosomal degradation inhibition.
Sala G; Arosio A; Stefanoni G; Melchionda L; Riva C; Marinig D; Brighina L; Ferrarese C
Biomed Res Int; 2013; 2013():846725. PubMed ID: 23984410
[TBL] [Abstract][Full Text] [Related]
17. LAMP2A as a therapeutic target in Parkinson disease.
Xilouri M; Brekk OR; Kirik D; Stefanis L
Autophagy; 2013 Dec; 9(12):2166-8. PubMed ID: 24145820
[TBL] [Abstract][Full Text] [Related]
18. Lysosomal degradation of alpha-synuclein in vivo.
Mak SK; McCormack AL; Manning-Bog AB; Cuervo AM; Di Monte DA
J Biol Chem; 2010 Apr; 285(18):13621-9. PubMed ID: 20200163
[TBL] [Abstract][Full Text] [Related]
19. Transcription factor NFE2L2/NRF2 modulates chaperone-mediated autophagy through the regulation of LAMP2A.
Pajares M; Rojo AI; Arias E; Díaz-Carretero A; Cuervo AM; Cuadrado A
Autophagy; 2018; 14(8):1310-1322. PubMed ID: 29950142
[TBL] [Abstract][Full Text] [Related]
20. DJ-1 Inhibits α-Synuclein Aggregation by Regulating Chaperone-Mediated Autophagy.
Xu CY; Kang WY; Chen YM; Jiang TF; Zhang J; Zhang LN; Ding JQ; Liu J; Chen SD
Front Aging Neurosci; 2017; 9():308. PubMed ID: 29021755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
